Morphologic cell profiling of SARS-CoV-2 infected cells enables drug repurposing screening

8 Feb 2022
Morphologic cell profiling of SARS-CoV-2 infected cells enables drug repurposing screening

In this video, the profiling of SARS-CoV-2 infected cells in order to repurpose drugs is discussed.

About the company

Yokogawa Corp. of America logo

Yokogawa Corp. of America

4.6/5.0
|3 Reviews

Other videos from Yokogawa Corp. of America

Links